EN
Türkçe
Deutsch
Français
Español
Português
Русский
العربية
中文
日本語
SPDR S&P Biotech ETF (XBI)
SPDR S&P Biotech ETF last traded at 154.84 USD. Over the past month the price moved -1.13%. Historical scenarios, expert targets and the plain-language read from AIsier.
One-year price chart
Last price
154.84 USD
- 1 week
- +1.04%
- 1 month
- -1.13%
- 3 months
- +4.69%
- 1 year
- +39.35%
- 52-week high
- 169.55 USD
- 52-week low
- 107.58 USD
Funds
- Symbol
- XBI
- Currency
- USD
- Exchange
- NYSE
AIsier's plain-language read
XBI has gained close to 30% this year, yet slipped about 4% over the last month.
What is going on right now?
After a strong run in 2024 and into this year, the price has drifted lower over the past month and now sits below where it was trading a few weeks ago. Daily activity has been quieter than usual too.
How is the business itself doing?
This is a basket of roughly equal-sized slices of many small and mid-sized biotech companies. No single company makes up more than about 2% of the total, so it spreads things out widely across the sector.
What stands out?
A recent report on how GLP-1 weight-loss drugs may affect the beauty and aesthetics space could draw fresh attention to some of the biotech trials inside this basket.
What comes next?
Individual drug trial results from holdings like Twist Bioscience or Moderna can move the basket quickly, since each piece is roughly the same size.
Historical scenarios that name this asset
FAQ
What is the current price of SPDR S&P Biotech ETF?
As of Oct. 27, 2026, the latest recorded price of SPDR S&P Biotech ETF (XBI) was 154.84 USD.
How has SPDR S&P Biotech ETF moved recently?
Measured from closing prices: +1.04% over one week, -1.13% over one month and +39.35% over one year.
Which historical scenarios name SPDR S&P Biotech ETF?
SPDR S&P Biotech ETF appears in 1 documented scenario: Drug Research & Approvals.